NCT05969600View on ClinicalTrials.gov

The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding L3

CompletedOBSERVATIONAL

Enrollment

521

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2022

Conditions

Leukemia, Acute

All Listed Sponsors

lead

Central Teaching Hospital of Peadiatrics, Baghdad

OTHER

NCT05969600 - The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding L3 | Biotech Hunter | Biotech Hunter